KPMG has been appointed administrators to Phion Therapeutics Limited, a Queen’s University spin-out that has raised over €25 million in equity since it was founded. Accountants James Neill and John Donaldson were appointed administrators to the Belfast-headquartered biotechnology company, which develops ground-breaking nucleic acid vaccines and therapeutics. Phion Therapeutics has raised funds from various private investors and Innovate UK. Its largest investor is invoX Pharma, an integrated biopharmaceutical company. InvoX Pharma was founded in March 2021 by Sion Biopharma, a Hong Kong-listed global top-40 pharmaceutical company. Phion Therapeutics’ lead product is a therapeutic vaccine against cancers driven by HPV (a…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .